Best HealthTech Companies in Carlsbad, United States
The 45 best HealthTech companies in Carlsbad, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Aira.
Our analysis of 305 HealthTech companies
$32.1b in tracked funding; 95% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best HealthTech companies in Carlsbad
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aira Provider of remote assistance solution for blinds and the visually impaired | $192M | 31 mo ago | Acquired | Troy Otillio Chief Executive Officer | 2014 | WordPressMySQLPHP+24 | 302 patents Multi-coil resonant wireless charging systems with advanced foreign-object detection | 1 job opening · 1 partnership |
| 2 | Medsphere Systems Open-source software provider for healthcare organizations | $151M | 57 mo ago | Series F | — | 2002 | WordPressApple iCloud MailMySQL+33 | — | — |
| 3 | Sotera Provider of continuous patient monitoring systems for patients and doctors | $136M | 109 mo ago | Series E | Shin Chia CEO | 2004 | HubSpot CMS HubHubSpotcore-js+21 | — | — |
| 4 | Equip Provider of virtual therapy and consultation for eating disorders 64Growth top 17%Funding top 18%Tech top 28%Moat top 28% All 10 signals ▾Growthtop 17% Fundingtop 18% Techtop 28% Moattop 28% Talenttop 38% Producttop 40% Marketbottom 42% Globalbottom 32% Newsbottom 18% Customersbottom 3% Growth: Headcount 15 → 32 (+113%) across vintages · Web rank 5,000,000 → 1,000,000 YoY Funding: Raised $130M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $130M | 13 mo ago | Series C | Kristina Saffran Cofounder and CEO | 2019 | PlasmicSanitySentry+32 | — | — |
| 5 | Allez Health Developing biosensor technologies in the field of continuous glucose monitoring | $60M | 27 mo ago | Series A | Ted Zhang Co-founder & Chief Scientific Officer | 2024 | — | — | — |
| 6 | JUMPCODE Genomics Provider of a technology for depleting unwanted nucleic acid | $39M | 17 mo ago | Series B | — | 2016 | WordPressZohoSalesforce+18 | 106 patents RNA sequencing library preparation and guide nucleic acid technologies for transcriptome analysis | — |
| 7 | Spectral Imaging Biomedical imaging solutions for pathology, cytogenetics, and life sciences | $19M | 311 mo ago | Series B | — | 1993 | WordPressMySQLPHP+20 | 24 patents Real-time multispectral imaging systems for medical and industrial diagnostics | — |
| 8 | BioSpyder Developer of molecular biology tools for gene expression | $17M | 38 mo ago | Funding Raised | — | 2011 | Squarespace CommerceSquarespaceTypeScript+16 | 7 patents Nucleic‑acid library prep and ligation‑based assays for transcriptome profiling | 1 launch · 2 partnerships · 1 expansion |
| 9 | Active Motif Provider of research kits, assays and biocomputing systems | $5M | 16 mo ago | Funding Raised | Joe Fernandez Founder | 1999 | Cart FunctionalityApple iCloud MailSalesforce+15 | 31 patents Epigenetic editing and detection of DNA/RNA chemical modifications | 1 partnership |
| 10 | Glucovation Developing continuous glucose, lactate, and other analyte monitoring technologies | $3M | 120 mo ago | Series A | Bob Boock Co-Founder & CEO | 2013 | — | 25 patents Electrochemical biosensor platforms for continuous glucose monitoring with reusable applicators | — |
| 11 | MDandMe AI-powered conversational symptom checker for individuals | $2M | 37 mo ago | Seed | Ilya Valmianski Co-Founder & CEO | 2023 | Node.jsGoogle Sign-inMUI+21 | — | — |
| 12 | Proactive Diagnostics Provider of diagnostic device for acute and chronic inflammation biomarkers | $2M | 45 mo ago | Seed | Reuven Duer Founder & CEO | 2017 | — | — | — |
| 13 | Global 1 Provider of bundled payment solutions for the healthcare industry | $459K | 76 mo ago | Funding Raised | Scott Leggett Founder | 2010 | — | — | — |
Top 12 HealthTech companies in Carlsbad
#1
Series C · Carlsbad, California · founded 2019 · 32 employees$130Mraised▾
Provider of virtual therapy and consultation for eating disorders. The company provides medical, psychiatric, dietary, therapeutic, and practical support for eating disorders and co-occurring illnesses such as PTSD, anxiety, substance use, and mood disorders. It includes medical services, overseen by a pediatrician and a psychiatrist, dietary services, and therapeutic services like an individual, family, and group therapy.
- Jul 2025Series C$54.1M
- Jun 2023Series C$35M
- Feb 2022Series B$58M
- Feb 2021Series A$13M
#2
Series B · Carlsbad, California · founded 2016 · 27 employees$38.7Mraised▾
JumpCode provides technology for depleting unwanted nucleic acid. The CRISPRclean is a proprietary technology that utilizes the CRISPR/CAS system to deplete unwanted nucleic acid molecules from sequencing libraries. The applications of the technology include host organism depletion, ribosomal RNA depletion, repetitive sequence depletion, allele-specific depletion, and others. The patented CRISPRclean technology allows the researcher to remove unwanted regions. The company provides products for RNA depletion suing the rRNA depletion kits or DNA depletion using the companies DNA Depletion kit.
- Feb 2025Grant (prize money)$383.7K
- Aug 2024Series B$3.5M
- May 2023Series B$9.2M
- Dec 2020Series B$21M
#3
Acquired · Carlsbad, California · founded 2014 · 4 employees$192.2Mraised▾
Provider of remote assistance solution for blinds and the visually impaired. It provides smart glasses app that enables users to connect with a network certified agents along with family and friends. The agents use a real-time interactive cloud-based dashboard built to provide an augmented reality context for remote users by the processing of live data streams from cameras, GPS, and other sensor systems from wearable platforms.
- Jan 2024Series B$158.8M
- Dec 2018Series B$17.2M
- Jul 2017Grant (prize money)$225K
- May 2017Series B$12M
#4
Funding Raised · Carlsbad, California · founded 1999 · 118 employees$4.5Mraised▾
Active Motif develops and distributes tools that enable epigenetics and gene regulation research. It offers products in the areas of gene regulation, epigenetics and chromatin, antibodies, protein detection and quantitation, recombinant proteins and enzymes, fluorescence, and bioinformatics. The company also provides antibodies, fluorescent dyes, kits, recombinant proteins, reporter assays and epigenetic services that include contract research services. It serves life science industries, and clinical and pharmaceutical/drug discovery communities.
- Apr 2025Grant (prize money)$314.3K
- Dec 2023Grant (prize money)$314.3K
- Sep 2018Grant (prize money)$2.1M
- Sep 2017Grant (prize money)$225K
#5
Series A · Carlsbad, California · founded 2024$60Mraised▾
Developing biosensor technologies in the field of continuous glucose monitoring. It provide integrated continuous glucose monitoring accuracy, delivering reliable data. The sensors integrate with various data platforms, allowing users to access the health data in real time.
- May 2024Series A$60M
#6
Series F · Carlsbad, California · founded 2002 · 352 employees$151.3Mraised▾
Medsphere Systems provides open source software for the healthcare industry. It offers OpenVista, a portfolio of products and professional services for hospitals, clinics, and integrated delivery networks. It includes OpenVista Enterprise, an electronic health record solution that offers patient and health information management system, clinical information system, laboratory, pharmacy, radiology, nutrition and food service, and interface suite modules. In addition, the company offers implementation, training, support, and development services.
- Oct 2021Conventional Debt$50M
- Jan 2020Series F$40M
- Dec 2018Series E$32M
- Jan 2018Series D$30M
#7
Funding Raised · Carlsbad, California · founded 2011 · 23 employees$17.4Mraised▾
Developer of molecular biology tools for gene expression. The company has developed a novel product for targeted sequencing called TempO-Seq, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, together with sequencing short fragments of each gene, enables pooling up to 6,144 samples in one sequencing run.
- Jun 2023Grant (prize money)$2.5M
- Apr 2021Grant (prize money)$402.3K
- Jan 2021Grant (prize money)$252.1K
- Aug 2020Grant (prize money)$225K
#8
Series E · Carlsbad, California · founded 2004 · 22 employees$135.9Mraised▾
Provider of continuous patient monitoring systems for patients and doctors. The company provides patient monitoring systems for step-down and general floor units, helping hospitals improve patient safety with minimum impact on clinical workflow. The company's flagship product, ViSi Mobile, is strapped to a patient's arm and monitors vital signs such as blood pressure, heart rate, pulse rate, respiratory rate, and skin temperature.
- Jul 2017Series E$31.8M
- Apr 2014Series E$53M
- Jan 2013Series D$5.8M
- Dec 2011Series D$12.2M
#9
Seed · Carlsbad, California · founded 2023$2Mraised▾
AI-powered conversational symptom checker for individuals. It serves as a personal symptom checker, allowing users to chat with medical AI about their symptoms and provide personalized recommendations.
- Jun 2023Seed$2M
#10
Series B · Carlsbad, California · founded 1993 · 80 employees$19Mraised▾
Biomedical imaging solutions for pathology, cytogenetics, and life sciences. The company develops advanced imaging platforms that streamline diagnostic workflows, from image acquisition to quantitative analysis and reporting. They offer computer-aided solutions for digital cytogenetics and pathology, catering to brightfield, fluorescence, and spectral imaging and analysis. With a focus on delivering advanced diagnostics and user-centric solutions, they provide technology in karyotyping, IHC, and FISH imaging and analysis. Their technology enhances accuracy and efficiency in digital pathology, IHC, and spectral imaging. They equip pathology and cytogenetic laboratories with biomedical imaging solutions powered by technologies and computer-aided workflows, aiming to reduce turnaround time.
- Aug 2000Series B$11M
- Nov 1998Series A$8M
#11
Seed · Carlsbad, California · founded 2017 · 3 employees$2Mraised▾
Provider of diagnostic device for acute and chronic inflammation biomarkers. The company offers 'Q-SENS' a novel point-of-care testing platform that combines multiplexing capabilities with central lab precision, enabling the simultaneous detection of proteins, nucleic acids, and small molecules in one affordable and quick test.
- Nov 2022Seed$2M
#12
Series A · Carlsbad, California · founded 2013 · 5 employees$2.9Mraised▾
Developing continuous glucose, lactate, and other analyte monitoring technologies. This company focuses on metabolic sensing technologies for continuous monitoring of glucose, lactate, and other analytes. Their innovative approach aims to provide real-time insights into metabolic health. The company is dedicated to advancing healthcare through cutting-edge sensor technology. They are currently in the investigational phase, signaling a commitment to rigorous research and development. This technology has the potential to transform how metabolic conditions are managed, offering a proactive approach to health monitoring. The company's work contributes to the broader field of medical technology, with a focus on improving patient outcomes through advanced sensing solutions.
- Aug 2016Series A$2M
- Sep 2014Seed$850K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Digital Health is moving in the United States
A read on the academic research around Digital Health — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 8,843 United States-affiliated papers.
- Design Intelligence421
- Harvard University383
- Johns Hopkins University295
- University of North Carolina at Chapel Hill206
- University of Washington173
- Health care9→240
- Wearable computer6→129
- Health informatics25→140
- Remote patient monitoring11→76
- Informatics10→60
- Health care36→766
- Health informatics113→495
- Psychological intervention20→320
- Public health34→290
- Intervention (counseling)5→193
- Health care98→1170
- Health informatics213→712
- Public health73→525
- Psychological intervention26→368
- Health administration110→363
Where digital health is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing medical devices patents in the United States
United States medical devices patent filing is accelerating — 666,693 filings from 8,000 assignees (2016–2025), led by Covidien, Boston Scient Scimed, Medtronic; annual filings 63466→63610.
- Covidien29348
- Boston Scient Scimed24762
- Medtronic22394
- Becton Dickinson18249
- Procter & Gamble16178
- Ethicon ENDO Surgery13723
- Kimberly Clark12440
- Ethicon11761
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.